Development and validation of psoriatic arthritis switch quality assessment tool (PASQAL) – an outcomes measurement tool to assess the quality of biologic switch decisions in psoriatic arthritis

Development and validation of psoriatic arthritis switch quality assessment tool (PASQAL) – an outcomes measurement tool to assess the quality of biologic switch decisions in psoriatic arthritis

Background: Switching between biologic therapies is a recommended strategy for Psoriatic Arthritis (PsA) patients that show an insufficient response or adverse events. Although the choice of the subsequent biologic may be dependent on many factors, assessing the quality of the switch decision is of...

Full description

Bibliographic Details
Main Authors: Pedro Almeida Laires, Magda Carrilho, José Tavares-Costa, Pedro Lucas, Pedro Machado, Luís Cunha-Miranda, Fernando Pimentel-Santos, Helena Santos, Elsa Vieira-Sousa, Maria José Santos
Format: Article
Language:English
Published: Sociedade Portuguesa de Reumatologia 2020-01-01
Series:Acta Reumatológica Portuguesa
Subjects:
psoriatic arthritis, biologic switch, consensus, outcomes measurement tools, therapeutic decisionspsoriatic arthritis, biologic switch, consensus, outcomes measurement tools, therapeutic decisions
Online Access:http://www.actareumatologica.pt/files/article/1296_development_and_validation_of_psoriatic_arthritis_switch_quality_assessment_tool_pasqal_an_outcomes_measurement_tool_to_assess_the_quality_of_biologic_switch_decisions_in_psoriatic_arthritis_file.pdf

Internet

http://www.actareumatologica.pt/files/article/1296_development_and_validation_of_psoriatic_arthritis_switch_quality_assessment_tool_pasqal_an_outcomes_measurement_tool_to_assess_the_quality_of_biologic_switch_decisions_in_psoriatic_arthritis_file.pdf

Similar Items